291 related articles for article (PubMed ID: 27183525)
1. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S45-54. PubMed ID: 27183525
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e45-e54. PubMed ID: 27755242
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: role of echocardiography.
Zito C; Longobardo L; Cadeddu C; Monte I; Novo G; Dell'Oglio S; Pepe A; Madonna R; Tocchetti CG; Mele D
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S35-44. PubMed ID: 27183524
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention.
Cadeddu Dessalvi C; Deidda M; Mele D; Bassareo PP; Esposito R; Santoro C; Lembo M; Galderisi M; Mercuro G
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):315-323. PubMed ID: 29708912
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: role of echocardiography.
Zito C; Longobardo L; Cadeddu C; Monte I; Novo G; Dell'Oglio S; Pepe A; Madonna R; Tocchetti CG; Mele D
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e35-e44. PubMed ID: 27755241
[TBL] [Abstract][Full Text] [Related]
6. The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics.
Parashar A; Hundley WG
Curr Cardiol Rep; 2018 Oct; 20(12):142. PubMed ID: 30367282
[TBL] [Abstract][Full Text] [Related]
7. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.
Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A
Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476
[TBL] [Abstract][Full Text] [Related]
8. A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
Maurea N; Spallarossa P; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e93-e104. PubMed ID: 27755247
[TBL] [Abstract][Full Text] [Related]
9. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
Garg V; Vorobiof G
Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
[TBL] [Abstract][Full Text] [Related]
10. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.
Spallarossa P; Maurea N; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1(Suppl 1):S84-92. PubMed ID: 27183529
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Research Tools for the Study of Cardiovascular Effects of Cancer Therapy.
Feroze RA; Leya J; Herron T; Hayek SS
J Cardiovasc Transl Res; 2020 Jun; 13(3):417-430. PubMed ID: 32472498
[TBL] [Abstract][Full Text] [Related]
12. Cardiac magnetic resonance imaging-based myocardial strain study for evaluation of cardiotoxicity in breast cancer patients treated with trastuzumab: A pilot study to evaluate the feasibility of the method.
Nakano S; Takahashi M; Kimura F; Senoo T; Saeki T; Ueda S; Tanno J; Senbonmatsu T; Kasai T; Nishimura S
Cardiol J; 2016; 23(3):270-80. PubMed ID: 27173679
[TBL] [Abstract][Full Text] [Related]
13. Advanced imaging modalities to detect cardiotoxicity.
Awadalla M; Hassan MZO; Alvi RM; Neilan TG
Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced cardiotoxicity: detection, prevention, and management.
Truong J; Yan AT; Cramarossa G; Chan KK
Can J Cardiol; 2014 Aug; 30(8):869-78. PubMed ID: 25064580
[TBL] [Abstract][Full Text] [Related]
15. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
[TBL] [Abstract][Full Text] [Related]
16. Cardiac imaging in cardiotoxicity: a focus on clinical practice.
Makavos G; Ikonomidis I; Palios J; Rigopoulos A; Katogiannis K; Parissis J; Paraskevaidis I; Noutsias M
Heart Fail Rev; 2021 Sep; 26(5):1175-1187. PubMed ID: 32306221
[TBL] [Abstract][Full Text] [Related]
17. Role of biomarkers in monitoring antiblastic cardiotoxicity.
Novo G; Cadeddu C; Sucato V; Pagliaro P; Romano S; Tocchetti CG; Zito C; Longobardo L; Nodari S; Penco M
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S27-34. PubMed ID: 27183522
[TBL] [Abstract][Full Text] [Related]
18. The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review.
Jafari F; Safaei AM; Hosseini L; Asadian S; Kamangar TM; Zadehbagheri F; Rezaeian N
Heart Fail Rev; 2021 May; 26(3):679-697. PubMed ID: 33029698
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Imaging for the Assessment of Cardiotoxicity from Chemotherapeutic Agents in Oncologic Disease.
Sreenivasan J; Hooda U; Ranjan P; Jain D
Curr Cardiol Rep; 2021 May; 23(6):65. PubMed ID: 33961140
[TBL] [Abstract][Full Text] [Related]
20. Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient.
Plana JC; Thavendiranathan P; Bucciarelli-Ducci C; Lancellotti P
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1173-1186. PubMed ID: 30092972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
